Member Info for rbr08

@warleb, I'm not going to have argument on here regarding this. But you are probably not looking at a correct link.
Have a look at this link - https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/rl.cfm?lid=703727&lpcd=QLT

This is a background update which happens every Monday. This has nothing to do with approval.
In addition, the twitter post is incorrect as I can find genedrive on the database.

@BoobyK: The product codes are for the 3 individual assays for their respective equipment.
1) ID-CoV2-01-LPC Genedrive 96 SARS-CoV-2 Kit – Low Profile Plate CE-IVD ------ Roche Lifecycler 480 II
2) ID-CoV2-01-FPC Genedrive 96 SARS-CoV-2 Kit - Fast Plate CE-IVD ------ ABI 7500 Fast
3) ID-CoV2-01-BPC Genedrive 96 SARS-CoV-2 Kit - Bio Plate CE-IVD ------ Bio Rad CFX96

https://www.genedrive.com/assays/sars-cov-2-kit-assay.php

Anyone care to shed some insight on this:

1) We have heard buyout talk fro many months - since back in May June last yr. Now that BC are on board what probability of a buyout becoming a reality?

2) What happens to shareholders shares - financial gain on buyouts? How to receive our capital and profits - and when?

@solstace, regarding BCs $4 antigen test, that is correct. DB confirmed that their antigen test is for Beckman Coulter Access analyser, which is an immunoassay analyser

@Punit101421:
have a look at BGFs website and this will better guide your understanding of their business model. They aim is to facilitate development/ growth for small business' and once the business is able to stand on its two feet and continue on its own, they leave. Business' are built on a model and stick to that regardless of what 'pot of gold' waits at the other end.
They have most likely more than doubled their investment via the loan conversions and subsequent sale.

BGF being out is an AMAZING outcome as its now removes that chunk of shares which were on offer for much less than any other II or PI would let it go for in such volume.

So that's my 2 cents there for you to reference. If you are on here to just stir up mischief then I suggest you follow BGFs business model and leave.

@technick: £100m+ is a very political assessemnt. hahaha. I think this has potential to be a multiple of 100mil

@Llloyd88: I just realised the link is posted does not take you to the correct page - 2 pages seem to have the same link. You can access the page I'm referring to by selecting the following form the menu: PRODUCTS - SARS COV 2 TEST (under Diagnostics).

@Lloyd88: I believe "Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables, Accessories " is used to be inclusive of all types of testing.

Sysmex Sars webpage has genedrive listed. The other testing kit there is from a Chinese manufacturer (recently added) so this will surely not be considered for any UK framework - with the governments aim to increase UK supply chain development.
(https://www.sysmex-europe.com/n/products/diagnostics/sars-cov-2.html)

@lornah: I had a look at Sysmex product line a while back and they did seem to have some of their own workflows/ equipment. On the Covid front though I don't think they only have 3rd party products for distribution (as per their Sars-Cov webpage). Just my observation - stand to be corrected

@Wolf76: Sysmex has been a distributor for genedrive for a long time (Primarily via Asia markets but with covid they open up to Europe distribution). It been on their website so not sure where on the website you were looking 2 days ago.

From what I was told, WHO approval now holds little weight - so I assume they will leave it there and when approved it approved. The big one will be FDA.

But I agree I said the same thing: "a world health org can even approve a handful of tests". No wonder we are in the state we are

@KR1 - why do you say that?

Good evening, ladies and gents..... I've just logged on to be very disappointed in seeing the low standard to which this board is currently setting itself. In the life-cycle of any public company, investors come and go. Knowledge is big and small. We set different targets, different timelines AND assess companies in different ways based on these factors and others.

To carry on trying to prove each other wrong or to prove who has the biggest head of knowledge is completely foolish. If we cant agree to disagree, then we are not in the same reality.

So folks, please lets not carry this trend into a new trading week and beyond. All the best and may the day come where GDR becomes a stronger and more successful diagnostic company!! Good night

The genedrive partnership webpage I'm not sure when it was created. It could be an old page that was never used in the end.
If anyone can advise more would be appreciated.

Just found this page today on BCs website where it highlights their work with GDR:
"Read the latest news releases about our collaborations with the U.S. Department of Health and Human Services, genedrive, and Fry Laboratories." - https://www.beckman.com/resources/product-applications/infectious-diseases

Also, this page "https://www.mybeckman.co/news/genedrive-partnership" currently has a re-direct on it. So seems that some work is being done on this url/webpage in the background.

@Pineapple288: we were added to the FDA non-EUA approval list back in December as per the RNS. So this is in itself is not linked to recent buys (unless the wider market is now reading this information - which is a stretch in my opinion). The last few days are more associated with the wider Diagnostic sector movements feeding off US and UK government announcements and tender awards being announced soon, plus some talk of mutations evading current vaccines.

However, we are currently not aware of any material sales via the US market. This does not mean nothing is being ironed out in the background as there has been some interesting findings on the BCs website (which is just speculative at the moment).

These Google searches are also starting to show new text on the Google results page itself (the actual page is not live yet).

"Beckman Coulter Life Sciences is taking actions in the best interests of our associates, customers, and business partners as we navigate the growing threats of ...

@Invest4theLT: also found BC's Brazil website version with a link to GDR/BC tie up

Yeah but 'drivegene' alone brings back no results.